United Therapeutics reported $800M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Baxter International BAX:US USD 16.15B 125M
Bayer BAYN:GR EUR 39.46B 1.4B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Esperion Therapeutics ESPR:US USD 259.49M 407K
Gilead Sciences GILD:US USD 22.95B 2.24B
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Insmed INSM:US USD 807.48M 366K
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Moderna Inc MRNA:US USD 922M 281M
Omeros OMER:US USD 439.82M 125.46M
Pfizer PFE:US USD 32.63B 1.66B
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Teva Pharmaceutical TEVA:IT USD 18.5B 1.87B
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M